Literature DB >> 21194299

Functional homogeneity in microRNA target heterogeneity--a new sight into human microRNomics.

Yingying Wang1, Lei Du, Xia Li, Shaojun Zhang, Yun Xiao, Binsheng Gong, Qianghu Wang, Meng Zhou, Chaohan Xu, Xin Chen, Sali Lv, Shaoqi Rao.   

Abstract

MicroRNomics is a novel genomics that studies the identification, targets, biological functions, etc., of microRNAs (miRNAs) on a genomic scale. Computational target prediction algorithms are important applications in microRNomics. However, the overlaps between target sets predicted by different algorithms for one miRNA are often small. Our work is initiated to find the reasons causing "heterogeneity" and investigate whether the heterogeneous targets are homogeneous on functional levels by integrating similarity metrics. The results suggest that most human miRNAs own heterogeneous targets. The dissimilarity of thermodynamic characteristics and the different treatment of 3'-compensatory sites adopted by algorithms are the main reasons for target "heterogeneity." Meanwhile, we find most miRNA heterogeneous targets are functional homogeneity because of the common principles such as sites conservation and G:U wobble pairs in different algorithms. Our findings reveal the "functional homogeneity in miRNA target heterogeneity." The conclusions provide a perspective of microRNomics on functional levels, which introduce a new sight into human miRNA targets.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21194299     DOI: 10.1089/omi.2010.0047

Source DB:  PubMed          Journal:  OMICS        ISSN: 1536-2310


  2 in total

1.  Obtaining Human Ischemic Stroke Gene Expression Biomarkers from Animal Models: A Cross-species Validation Study.

Authors:  Yingying Wang; Yunpeng Cai
Journal:  Sci Rep       Date:  2016-07-13       Impact factor: 4.379

2.  The Synergistic Effects of 5-Aminosalicylic Acid and Vorinostat in the Treatment of Ulcerative Colitis.

Authors:  Long He; Shuting Wen; Zhuotai Zhong; Senhui Weng; Qilong Jiang; Hong Mi; Fengbin Liu
Journal:  Front Pharmacol       Date:  2021-05-21       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.